Amanote Research
Register
Sign In
Local Delivery of IFNα Has Antitumor Activity in Bladder Cancer
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2017-163
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
September 1, 2017
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
1,25D3 Enhances Antitumor Activity of Gemcitabine and Cisplatin in Human Bladder Cancer Models
Cancer
Cancer Research
Oncology
Larotrectinib Has Antitumor Activity in TRK + Pediatric Solid Tumors
Cancer Discovery
Oncology
A Developed STING Agonist Has Systemic Antitumor Activity
Cancer Discovery
Oncology
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells
Cancer immunology research
Cancer Research
Immunology
GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma
Cancer Discovery
Oncology
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Role of Chitosan Co-Formulation in Enhancing Interleukin-12 Delivery and Antitumor Activity
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
Liposomal Vector Mediated Delivery of the 3p FUS1 Gene Demonstrates Potent Antitumor Activity Against Human Lung Cancer in Vivo
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Antitumor Effect of dsRNA-induced P21WAF1/Cip1 Gene Activation in Human Bladder Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology